Sign in
CompletedNo phase

Can a Dedicated Chronic Limb-threatening Ischaemia (CLTI) Clinic Improve Patient Self-reported Quality of Life

Key facts

Who runs it
The Leeds Teaching Hospitals NHS Trust
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
17 Nov 2022
Ended
1 Aug 2024
Type of study
Observational
Treatments tested
  • CLTI Clinic
Record updated
14 February 2025

Who can take part

Age
18 years to 105 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • All patients seen and assessed in the CLTI clinic

Who cannot take part

  • Patients with chronic venous insufficiency
  • Patients with diabetic foot infection
  • Patients with significant cognitive impairment such that they are unable to answer the questions
  • Patients without a confirmed diagnosis of CLTI

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

CLTI is the most severe form of peripheral arterial disease. Patients with the condition require investigation and management (typically in the form of revascularisation surgery) to salvage the limb. Traditionally, patients with the condition are admitted into hospital for their management, but with the advent of regional vascular networks, this is becoming increasingly difficult.

Read full original descriptionShow less

Recently, the Vascular Society of Great Britain and Ireland have advocated for the use of dedicated CLTI clinics to overcome this problem. Whilst there is burgeoning evidence for their clinical benefit, there is a lack of patient reported outcomes to measure their impact on patient selr-reported quality of life. We would like to determine if this service benefits its users as much as the clinical outcomes suggest it does.

The group in the trial

  • CLTI clinic patients

    This is a repeated measures study design. Eligible patients are opportunistically recruited into the study, and if successfully enrolled are given the EuroQoL 5-D to complete. Whether they undergo a revascularization procedure or not, the EuroQol 5-D is administered again at 6-12 weeks and again at 1 year after their initial assessment

    Treatment: CLTI Clinic

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Can a Dedicated Chronic Limb-threatening Ischaemia (CLTI) Clinic Improve Patient Self
Record updated
14 February 2025